Advancing Life and Liberty Through Action

Must Be the Money...

Aug 12, 2020

There are significant financial motivations behind many people on the board of the National Institutes of Health (NIH) that bias their recommendations regarding COVID-19 … and they do not align with your best interest. At the same time, Big Tech is actively hiding the truth from the nation: that there is a cheap, readily available, effective treatment for COVID-19.

Today, I will pull back the curtain for you and reveal the Deep State in some of America’s government advisors and how it’s reflected in medical opinions.

Now is the time to end this censorship and get life-saving truth into the hands of the American people. Section 230 of the Communications Decency Act gives Big Tech complete legal immunity for censoring and silencing the truth. And the Federal Communications Commission and the Federal Trade Commission have the authority to act to protect your right to speak and receive information on the internet. On the heels of congressional testimony and a presidential directive, now is our opportunity to demand that they take action to stop the censorship.

Send your fax today to demand these Tech giants be held accountable. -Mat

On the board of Dr. Anthony Fauci’s National Institutes of Health (NIH), many members have financial ties to Gilead Sciences, which holds the patent for remdesivir. That drug only works on severe cases of hospitalized COVID-19 patients to reduce their recovery time—and it is not very effective. The cost of the drug ranges from 3,700 to 5,200 dollars. Hydroxychloroquine (HCQ), on the other hand, is a generic drug approved for over 65 years, and it is very effective in the early stages of COVID. The cost is 10 dollars.

Dr. Harvey Risch, M.D., Ph.D., and an epidemiologist at Yale University, estimates that 100,000 people have died in America because they did not receive HCQ.

So, why the pushback against HCQ? Many NIH board members have financial ties to Gilead, which produces the less effective drug used when the patient is hospitalized.

Sharyl Attkisson, an investigative reporter and TV anchor, said of the board choosing treatment options for COVID-19:

"When it comes to money, we checked financial ties among experts on the government panel devising coronavirus treatment guidelines— which had the effect of dialing back hydroxychloroquine use and giving an edge to remdesivir. We found that of 11 members reporting links to a drug company, nine of them named relationships to remdesivir’s maker Gilead. Seven more, including two of the committee’s leaders, have ties to Gilead beyond the 11 months they had to disclose. Two were on Gilead’s advisory board. Others were paid consultants or received research support and honoraria."

"Nobody reported ties to hydroxychloroquine."

Upon completion of remdesivir’s production, those in the U.S. government "reportedly bought almost all of Gilead Sciences’ supply" of this drug.

But that’s not all. Another NIH board member has ties to Ansun Biopharma, a company that publicly announced on April 2 "Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment." This treatment came about three weeks after the World Health Organization declared a pandemic and would also be in direct competition with HCQ.

Another NIH board member is invested in 3M, and her spouse works for 3M. This company produces respirators and ventilators. "Since the outbreak began, 3M has doubled its global output of N95 respirators." And if COVID-19 became an easily managed disease, this demand would go away.

Of the 55 board members, they had 25 disclosed potential conflicts of interest.

And Facebook, Youtube, and Twitter are censoring life-saving truth that provides the best second option to save lives.

Now is the time to shine light into this darkness and hold accountable the tech giants that are aiding and abetting the misleading of Americans. Send your fax now to make sure those speaking the truth will be heard.

 

Unfortunately, it’s not just the NIH board members that have conflicts.

One of the researchers of the widely touted Department of Veterans Affairs study used to discredit HCQ was S. Scott Sutton. He had just received a $247,000 grant in 2018 from Gilead Sciences, producer of remdesivir. In addition, the study also lists co-author Jayakrishna Ambati as having a pending patent "relating to COVID-19."

This so-called "study" had several faults. It was not peer-reviewed; it did not use zinc, which is a key part of HCQ’s efficacy; the people in the study were given HCQ late, when it is less effective; and it never reported the dosages, which is a critical factor.

Finally, an earlier published version of this VA study admits that: "hydroxychloroquine, with or without azithromycin, was more likely to be prescribed to patients with more severe disease. …Thus, as expected, increased mortality was observed." (emphasis added) This was NOT a randomized study, the results were intentionally skewed, and then that information was deleted and hidden, but not before a screen shot was captured by Patrick Howley.

Now is the time to end the control and censorship of these Big Tech companies through Congress, the FCC, and FTC. Send your fax today demanding our First Amendment freedoms be protected in the 21st century.

 

As I noted above, Dr. Harvey Risch of Yale estimates 100,000 Americans died unnecessarily because they were not given HCQ for COVID-19.

But both Democrat and Republican legislators are expressing serious concern about these corporations and now is the time to strike. Demand this censorship power be broken by Congress, the FCC, and the FTC immediately. Send your fax now.

 

Last year, Gilead Sciences spent 5.7 million dollars lobbying in D.C. However, there is no money to be made in HCQ at 10 dollars a treatment. At LCA, our goal is to champion the truth, no matter how unpopular it may seem.

We can only continue in this vision because of the faithful support of freedom-loving Americans who partner with us to get the truth and help into the hands of Americans who are dying needlessly right now.

I ask you to partner with us through a one-time or recurring donation today. The battle is intensifying, and, with your help, I want to mount a powerful defense of our freedom of speech and your right to hear the truth.

Thank you from the bottom of my heart.

Sincerely,

Mat Staver, Chairman
Liberty Counsel Action

P.S. Now is the time to break the stranglehold that Big Tech and Big Pharma have on truth. Lives are at stake right now. Send a fax demanding that legislators and the FCC move to protect the freedom of information and free speech.

I also invite you to forward this message to likeminded friends who want to see free speech preserved in America. And then sign our petition to protect our liberties.

Our ministry depends completely on the donations of friends and patriots across America. If you can support Liberty Counsel Action with a donation of any size today, I would be grateful. God bless.



Sources:

National Institutes of Health. Appendix A, Table 2. COVID-19 Treatment Guidelines Panel Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics. (Updated: 2020, June 30).

Ballasy, Nicholas. Just the News. Ten experts on a NIH COVID-19 panel have ties to companies involved in coronavirus treatment. (2020, August 11).

Attkisson, Sharyl and Full Measure Staff. Full Measure. Hydroxychloroquine (2020, May 17).

Magagnoli, Joseph. Siddharth Narendran, Felipe Pereira, Tammy Cummings, James W Hardin, S Scott Sutton, and Jayakrishna Ambati. MedEXIV. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 (Updated: 2020, April 23)

College of Pharmacy at the University of South Carolina. Twitter. "Congratulations! Dr. Scott Sutton has received a research grant from Gilead for $247,000." (2018, April 24).

Howley, Patrick. National File. BUSTED: Media Uses VA ‘Study’ To Launch Easily Debunked Attack On Hydroxychloroquine. (2020, April 22).

Open Secrets. Gilead Sciences. Annual Lobbying Totals: 1998 – 2019. (Accessed: 2020, August 11).



TAKE ACTION